Literature DB >> 2105266

Neurofibromatosis-1: a maximum likelihood estimation of mutation rate.

M Clementi1, G Barbujani, L Turolla, R Tenconi.   

Abstract

Methods of classical segregation analysis were applied to a sample of 129 sibships with one or more individuals affected by neurofibromatosis-1 (NF-1). The sample consists only of subjects with NF-1; all the probands had been referred for genetic counselling because of café-au-lait spots, and a diagnostic protocol was invariably applied. No deviation from the segregation ratio expected for a fully penetrant Mendelian dominant gene was observed. A maximum likelihood estimate of the proportion of sporadic cases was obtained, and the mutation rate was estimated to be 6.5 x 10(-5) gametes per generation (95% CI 5.0-8.1).

Entities:  

Mesh:

Year:  1990        PMID: 2105266     DOI: 10.1007/bf00208923

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  6 in total

1.  On the mutation rate of neurofibromatosis.

Authors:  A S Sergeyev
Journal:  Humangenetik       Date:  1975-06-19

2.  Genetic tests under incomplete ascertainment.

Authors:  N E MORTON
Journal:  Am J Hum Genet       Date:  1959-03       Impact factor: 11.025

3.  Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

Authors:  S M Huson; P S Harper; D A Compston
Journal:  Brain       Date:  1988-12       Impact factor: 13.501

4.  The pathophysiology of neurofibromatosis: IX. Paternal age as a factor in the origin of new mutations.

Authors:  V M Riccardi; C E Dobson; R Chakraborty; C Bontke
Journal:  Am J Med Genet       Date:  1984-05

5.  A refined genetic map of the region of chromosome 17 surrounding the von Recklinghausen neurofibromatosis (NF1) gene.

Authors:  S R Diehl; M Boehnke; R P Erickson; L M Ploughman; K A Seiler; J L Lieberman; H B Clarke; M A Bruce; E K Schorry; M Pericak-Vance
Journal:  Am J Hum Genet       Date:  1989-01       Impact factor: 11.025

6.  Neurofibromatosis. A clinical and genetic study of 96 cases in Gothenburg, Sweden.

Authors:  B Samuelsson; R Axelsson
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1981
  6 in total
  16 in total

1.  Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer.

Authors:  Emma Edwards; Catharina Yearwood; Julie Sillibourne; Diana Baralle; Diana Eccles
Journal:  Fam Cancer       Date:  2009-07-21       Impact factor: 2.375

2.  Linkage analysis of neurofibromatosis type 1. Study of a homogeneous North Italian population with five DNA markers of chromosome 17.

Authors:  M Clementi; A Murgia; F Anglani; R Tenconi; L Turolla; L Picci; F Zacchello
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

3.  Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.

Authors:  Eva Trevisson; Matteo Cassina; Enrico Opocher; Virginia Vicenzi; Marta Lucchetta; Raffaele Parrozzani; Giacomo Miglionico; Rodica Mardari; Elisabetta Viscardi; Edoardo Midena; Maurizio Clementi
Journal:  J Neurooncol       Date:  2017-06-02       Impact factor: 4.130

4.  Neurofibromatosis type 1 and type I Chiari malformation: an unusual association.

Authors:  P A Battistella; G Perilongo; C Carollo
Journal:  Childs Nerv Syst       Date:  1996-06       Impact factor: 1.475

5.  Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain.

Authors:  R Fahsold; S Hoffmeyer; C Mischung; C Gille; C Ehlers; N Kücükceylan; M Abdel-Nour; A Gewies; H Peters; D Kaufmann; A Buske; S Tinschert; P Nürnberg
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

6.  Regression of gadolinium-enhanced lesions in patients affected by neurofibromatosis type 1.

Authors:  Marta Lucchetta; Renzo Manara; Giorgio Perilongo; Maurizio Clementi; Eva Trevisson
Journal:  Radiol Med       Date:  2015-10-07       Impact factor: 3.469

7.  Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?

Authors:  Eric Pasmant; Béatrice Parfait; Armelle Luscan; Philippe Goussard; Audrey Briand-Suleau; Ingrid Laurendeau; Corinne Fouveaut; Chrystel Leroy; Annelore Montadert; Pierre Wolkenstein; Michel Vidaud; Dominique Vidaud
Journal:  Eur J Hum Genet       Date:  2014-07-30       Impact factor: 4.246

8.  Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma.

Authors:  David H Gutmann; Michael D McLellan; Ibrahim Hussain; John W Wallis; Lucinda L Fulton; Robert S Fulton; Vincent Magrini; Ryan Demeter; Todd Wylie; Cyriac Kandoth; Jeffrey R Leonard; Abhijit Guha; Christopher A Miller; Li Ding; Elaine R Mardis
Journal:  Genome Res       Date:  2012-12-05       Impact factor: 9.043

Review 9.  Tumor-suppressor genes: cardinal factors in inherited predisposition to human cancers.

Authors:  H J Evans; J Prosser
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

10.  The effect of parental age on the presence of de novo mutations - Lessons from neurofibromatosis type I.

Authors:  Tom Dubov; Hagit Toledano-Alhadef; Felix Bokstein; Shlomi Constantini; Shay Ben-Shachar
Journal:  Mol Genet Genomic Med       Date:  2016-06-16       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.